Status:
COMPLETED
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
The survey is conducted to collect safety and effectiveness information in Parkinson's Disease patients treated with Pramipexole without concomitant L-Dopa supplementation in the daily clinical settin...
Eligibility Criteria
Inclusion
- Patients with Parkinson's disease who do not receive L-Dopa supplementation
Exclusion
- Patients should have been treated according to the Japanese insert slip
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT00613301
Start Date
February 1 2004
Last Update
June 6 2014
Active Locations (119)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 11
Akita, Japan
2
Boehringer Ingelheim Investigational Site 95
Anan, Japan
3
Boehringer Ingelheim Investigational Site 1
Asahikawa, Japan
4
Boehringer Ingelheim Investigational Site 2
Asahikawa, Japan